Stonepine Capital Management »

Connect Biopharma Hldgs shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Connect Biopharma Hldgs (CNTB) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Connect Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Connect Biopharma Hldgs held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Connect Biopharma Hldgs by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $812k 310k 2.62

More positions owned by Stonepine Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Evolus (EOLS)
Camp4 Therapeutics Corp (CAMP)
Nektar Therapeutics Com New (NKTR)
Terns Pharmaceuticals Call Option (TERN)
Zevra Therapeutics Com New (ZVRA)
Abeona Therapeutics Com New (ABEO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Establishment Labs Holdings Ord Call Option (ESTA)
Kazia Therapeutics Sponsored Ads (KZIA)
An2 Therapeutics (ANTX)
Alexandria Real Estate Equities Call Option (ARE)

View all positions for Stonepine Capital Management

Top funds holding Connect Biopharma Hldgs

Ikarian Capital
Boothbay Fund Management
683 Capital Management
Perceptive Advisors
ADAR1 Capital Management
Richmond Brothers
Millennium Management
BML Capital Management
Knott David M Jr
Susquehanna International
Stonepine Capital Management
Propel Bio Management
Diadema Partners
Burkehill Global Management
Renaissance Technologies

View all funds holding Connect Biopharma Hldgs